PRODUCT OVERVIEW

Skinbrite Cream is a topical medicine used for the treatment of melasma, a skin condition characterized by dark patches on the face. It is intended for external use only and should be used under medical supervision for short term, intermittent treatment. The cream helps reduce skin pigmentation and improve the appearance of facial melasma when combined with proper sun protection.

KEY USES AND BENEFITS

Skinbrite Cream is used for the treatment of melasma. Melasma commonly appears as dark patches on the face and is often associated with sun exposure and hormonal changes. The cream helps reduce excess melanin production and promotes skin cell turnover, allowing dark patches to fade more evenly. Regular use as prescribed, along with strict sun protection, can improve the appearance of affected skin.

COMPOSITION AND HOW IT WORKS

Skinbrite Cream contains three active ingredients: Hydroquinone, Mometasone, and Tretinoin. Hydroquinone reduces excess melanin formation in the skin, helping to lighten dark patches. Mometasone is a corticosteroid that reduces inflammation, redness, and irritation associated with treatment. Tretinoin is a vitamin A derivative that increases skin cell turnover, helping melanin disperse more evenly and improving the appearance of the skin. Together, these ingredients work to reduce pigmentation and improve melasma when used under medical supervision.

DIRECTIONS FOR USE

Skinbrite Cream is for external use only. Use it exactly as directed by your doctor. Clean and dry the affected area before application. Apply a thin layer of the cream to the affected area and wash your hands after applying unless the hands are the treated area. Do not use more than the recommended amount or continue treatment for longer than prescribed. Avoid contact with the eyes, mouth, and other mucous membranes.

SIDE EFFECTS

Skinbrite Cream may cause burning, irritation, itching, redness, dryness, and a stinging sensation at the application site. These side effects are usually mild and temporary and often improve as the skin adjusts to treatment. Consult your doctor if any side effect persists, worsens, or becomes troublesome.

SAFETY ADVICE

Use Skinbrite Cream only under medical supervision and for short term treatment. Avoid direct sun exposure and ultraviolet light during treatment, as they may cause repigmentation of treated areas. Apply sunscreen regularly while using this medicine. The cream is intended for use on the face only and should not come into contact with the eyes, mouth, or mucous membranes. The safety of this medicine has not been established in pregnant women or children below 12 years of age. Breastfeeding women should consult their doctor before use. Stop treatment and seek medical advice if you develop severe irritation, hypersensitivity, or worsening of skin symptoms. Regular follow up with your doctor and consistent sun protection are important for achieving the best results in the treatment of melasma.